15-LOX-2 and its metabolites are outstanding exceptions to this rule: they appear linked to the suppression of prostate cancer in part because these metabolites inhibit proliferation [15], [19], [20], [22], [24], [25], [26]. Here, ALOX15B is linked to prostate carcinoma.